↓ Skip to main content

American Association for Cancer Research

Article Metrics

Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, March 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
10 news outlets
blogs
3 blogs
policy
1 policy source
twitter
20 tweeters
patent
1 patent
facebook
4 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
273 Dimensions

Readers on

mendeley
176 Mendeley
Title
Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity
Published in
Cancer Epidemiology, Biomarkers & Prevention, March 2015
DOI 10.1158/1055-9965.epi-14-1418
Pubmed ID
Authors

Siobhan M. Phillips, Lynne S. Padgett, Wendy M. Leisenring, Kayla K. Stratton, Ken Bishop, Kevin R. Krull, Catherine M. Alfano, Todd M. Gibson, Janet S. de Moor, Danielle Blanch Hartigan, Gregory T. Armstrong, Leslie L. Robison, Julia H. Rowland, Kevin C. Oeffinger, Angela B. Mariotto

Abstract

No studies have estimated the population-level burden of morbidity in individuals diagnosed with cancer as children (ages 0-19 years). We updated prevalence estimates of childhood cancer survivors as of 2011 and burden of morbidity in this population reflected by chronic conditions, neurocognitive dysfunction, compromised health-related quality of life, and health status (general health, mental health, functional impairment, functional limitations, pain, and fear/anxiety). Surveillance, Epidemiology, and End Results (SEER) Program data from 1975 to 2011 were used to update the prevalence of survivors of childhood cancers in the United States. Childhood Cancer Survivor Study data were used to obtain estimates of morbidity burden indicators, which were then extrapolated to SEER data to obtain population-level estimates. There were an estimated 388,501 survivors of childhood cancer in the United States as of January 1, 2011, of whom 83.5% are ≥5 years after diagnosis. The prevalence of any chronic condition among ≥5-year survivors ranged from 66% (ages 5-19) to 88% (ages 40-49). Estimates for specific morbidities ranged from 12% (pain) to 35% (neurocognitive dysfunction). Generally, morbidities increased by age. However, mental health and anxiety remained fairly stable, and neurocognitive dysfunction exhibited initial decline and then remained stable by time since diagnosis. The estimated prevalence of survivors of childhood cancer is increasing, as is the estimated prevalence of morbidity in those ≥5 years after diagnosis. Efforts to understand how to effectively decrease morbidity burden and incorporate effective care coordination and rehabilitation models to optimize longevity and well-being in this population should be a priority. Cancer Epidemiol Biomarkers Prev; 24(4); 653-63. ©2015 AACR.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 175 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 34 19%
Researcher 21 12%
Student > Master 18 10%
Student > Bachelor 18 10%
Student > Doctoral Student 17 10%
Other 34 19%
Unknown 34 19%
Readers by discipline Count As %
Medicine and Dentistry 57 32%
Psychology 23 13%
Nursing and Health Professions 22 13%
Biochemistry, Genetics and Molecular Biology 9 5%
Social Sciences 5 3%
Other 20 11%
Unknown 40 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 108. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2021.
All research outputs
#227,472
of 17,634,657 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#97
of 3,968 outputs
Outputs of similar age
#3,608
of 232,814 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#2
of 67 outputs
Altmetric has tracked 17,634,657 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,968 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.